Key regions: Australia, Brazil, United Kingdom, Europe, Canada
The demand for Other Vaccines in Mozambique has seen a steady rise in recent years due to various factors.
Customer preferences: Mozambique has a high infant mortality rate, and vaccination is an essential tool to prevent the spread of diseases. The government has been actively promoting vaccination programs across the country, which has led to increased awareness among the population. Additionally, the country has seen an increase in the number of people traveling abroad, which has led to a rise in demand for vaccines against diseases such as yellow fever and meningitis.
Trends in the market: The Other Vaccines market in Mozambique has witnessed a shift in demand from traditional vaccines to newer vaccines that offer better protection against diseases. The demand for vaccines against HPV and Hepatitis B has increased significantly in recent years, primarily due to the rising incidence of these diseases. Furthermore, the government's focus on increasing vaccination coverage and the introduction of new vaccines in the national immunization program have also contributed to the growth of the market.
Local special circumstances: Mozambique is a country with a high burden of infectious diseases, and the government has been working towards reducing the incidence of these diseases through vaccination programs. However, the country faces several challenges, such as inadequate healthcare infrastructure, lack of trained healthcare personnel, and limited financial resources. These factors have hindered the implementation of effective vaccination programs in the country.
Underlying macroeconomic factors: Mozambique is one of the fastest-growing economies in Africa, and the government has been investing heavily in the healthcare sector. The country has received significant support from international organizations such as WHO and UNICEF to improve its healthcare infrastructure and increase vaccination coverage. Additionally, the increasing number of partnerships between vaccine manufacturers and the government has led to the introduction of new vaccines in the market. However, the country still faces challenges such as high poverty rates and political instability, which may impact the growth of the market in the future.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
